Status:
COMPLETED
Bacterial Surinfections in COVID-19 ICU Patients
Lead Sponsor:
Jessa Hospital
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to assess the incidence of bacterial surinfections (sepsis, VAP and catheter infections) in COVID-19 patients admitted to the ICU from 13th of March 2020 until 17h of October ...
Detailed Description
Approximately 5% of patients with respiratory impairment develop a severe form with acute respiratory failure and require specialized management in the Intensive Care Unit (ICU). Invasive mechanical v...
Eligibility Criteria
Inclusion
- All adult COVID-19 patients admitted to the ICU from 13th of March until 17th of October 2020 were included.
Exclusion
- None
Key Trial Info
Start Date :
August 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 15 2021
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT04877808
Start Date
August 15 2021
End Date
August 15 2021
Last Update
August 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jessa hospital
Hasselt, Belgium, 3500